Skip to main content

GRAIL, Inc.

For the period ended Dec 31, 2025. Filed Mar 12, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 12, 2026

GRAL$124.74-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands)

Year Ended
December 31,2025December 31,2024December 31,2023
Cash flows from operating activities
Net loss$(408,351)$(2,027,005)$(1,465,685)
Adjustments to reconcile net loss to net cash used by operating activities:
Amortization of intangibles assets138,334138,333138,333
Depreciation18,01019,72320,364
Stock-based compensation expense58,28386,08497,235
Deferred income taxes(126,153)(134,251)(38,153)
Amortization of discount on marketable securities(21,217)(3,167)—
Goodwill and intangible assets impairment28,0001,420,936718,466
Credit loss expense332——
Cash payment for equity awards—(53,807)(76,910)
Other1,3472762,829
Changes in operating assets and liabilities:
Accounts receivable(1)1,685(3,370)(1,383)
Supplies(2)2,6153,073(1,940)
Operating lease right-of-use assets and liabilities, net1,0251,7476,712
Prepaid expenses and other assets(3)3,3601,823(908)
Accounts payable(4)(2,733)(14,635)2,889
Accrued and other liabilities(5)6,456(12,916)2,351
Net cash used by operating activities(299,007)(577,156)(595,800)
Cash flows from investing activities
Purchases of property and equipment(6)(909)(5,208)(12,887)
Purchases of marketable securities(1,308,340)(545,803)—
Proceeds from maturities of marketable securities1,224,200——
Net cash used in investing activities(85,049)(551,011)(12,887)
Cash flows from financing activities
Proceeds from issuance of common stock and pre-funded warrants in connection with the PIPE, net of issuance costs311,319——
Proceeds from issuance of common stock in connection with the ATM program, net of issuance costs107,477——
Issuance of common stock under ESPP4,525——
Cash funding received from Illumina—1,244,300464,000
Other——(234)
Net cash provided by financing activities423,3211,244,300463,766
Effect of exchange rate changes on cash, cash equivalents, and restricted cash(147)(62)305
Net increase (decrease) in cash, cash equivalents, and restricted cash39,118116,071(144,616)
Cash, cash equivalents and restricted cash — beginning of period217,583101,512246,128
Cash, cash equivalents and restricted cash — end of period256,701217,583101,512
Represented by:
Cash and cash equivalents249,727214,23497,287
Restricted cash6,9743,3494,225
Total$256,701$217,583$101,512
Supplemental cash flow information:
Property and equipment included in accounts payable and accrued liabilities$(42)$—$(1,326)
Operating cash flows from operating leases, net$(17,174)$(19,272)$(18,733)

(1) Includes changes in related party accounts receivable of $(65), $15 and $133, respectively.

(2) Includes changes in related party supplies of $(3,130), $2,725 and $(871), respectively.

(3) Includes changes in related party prepaid and other current assets of $(77), $(36) and $27, respectively.

(4) Includes changes in related party accounts payable ofnil, $(168) and $(2,965), respectively.

(5) Includes changes in related party accrued liabilities of $104, $9 and $91, respectively.

(6) Includes related party purchases of property and equipment of $(591), nil and $(2,644), respectively.

See accompanying notes to Consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.